US FDA grants fast track designation to Clarity Pharma’s Cu-64 SAR-bisPSMA in biochemical recurrence of prostate cancer: Sydney, Australia Monday, January 27, 2025, 14:00 Hrs [I ...

In this interview, Technology Networks spoke with Dr. Sophie Mayle, Dr. Paul Royle and Dr. John Cardone from Bio-Rad's custom antibody services team, to learn more about the developments and future ...

Model was trained based on 89 manually contoured cases and tested on a cohort of patients receiving therapy with 177 Lu-prostate-specific membrane antigen-617 ... which returned the label map as a ...

Antigen processing and presentation is the mechanism by which whole antigens are degraded and loaded onto MHC molecules for display on the cell surface for recognition by T cells. Both macrophages ...

The year 2015 marked the inception of Sanyou Bio's technological journey, laying the foundation for its core technology platform. The R&D team devoted itself to the development of display vectors, ...

Uniform protein labeling in intact tissues is a challenge. An approach that allows antibodies to seep within organs could ...

Clarity Pharmaceuticals ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and ...

The introduction of the prostate-specific antigen (PSA) test was seen as revolutionary for the prostate cancer community. Initially approved to monitor disease progression in the 1980s and cancer ...

Nutrition labels on your favorite grocery items may soon sport a new look. The Food and Drug Administration announced a new proposal Tuesday that would require food and drink manufacturers to ...

Senator Bill Cassidy, a physician and key G.O.P. vote, joined Democrats in aggressively questioning Robert F. Kennedy Jr., ...